Skip to main content

Advertisement

Log in

Transcription factor SOX3 upregulated pro-apoptotic genes expression in human breast cancer

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Background

Sex-determining region Y-box 3 (SOX3) protein, a SOX transcriptions factors group, has been identified as a key regulator in several diseases, including cancer. Downregulation of transcriptions factors in invasive ductal carcinoma (IDC) can interfere in neoplasia development, increasing its aggressiveness. We investigated SOX3 protein expression and its correlation with apoptosis in the MDA-MB-231 cell line, as SOX3 and Pro-Caspase-3 immunoexpression in paraffin-embedded invasive ductal carcinoma tissue samples from patients (n = 27). Breast cancer cell line MDA-MD-231 transfected with pEF1-SOX3 + and pEF1-Empty vector followed by cytotoxicity assay (MTT), Annexin-V FITC PI for apoptosis percentage assessment by flow cytometry, qPCR for apoptotic-related gene expression, immunofluorescence, and immunohistochemistry to SOX3 immunolocalization in culture cells, and paraffin-embedded invasive ductal carcinoma tissue samples.

Results

Apoptotic rate was higher in cells transfected with pEF1-SOX3 + (56%) than controls (10%). MDA-MB-231 transfected with pEF1-SOX3 + presented upregulation of pro-apoptotic mRNA from CASP3, CASP8, CASP9, and BAX genes, contrasting with downregulation antiapoptotic mRNA from BCL2, compared to non-transfected cells and cells transfected with pEF1-empty vector (p < 0.005). SOX3 protein nuclear expression was detected in 14% (4/27 cases) of ductal carcinoma cases, and pro-Caspase-3 expression was positive in 50% of the cases.

Conclusion

Data suggest that SOX3 transcription factor upregulates apoptosis in breast cancer cell line MDA-MB-231, and has a down nuclear expression in ductal carcinoma cases, and need to be investigated as a tumor suppressor protein, and its loss of expression and non-nuclear action turn the cells resistant to apoptosis. Further studies are necessary to understand how SOX3 protein regulates the promoter regions of genes involved in apoptosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

Not applicable.

Abbreviations

TFs:

Transcription factors

IDC:

Invasive ductal carcinoma

HMG:

High-mobility group

EMT:

Epithelial mesenchymal transition

IHC:

Immunohistochemistry

DMEM:

Dulbecco’s modified eagle medium

PBS:

Phosphate buffered saline

GFP:

Green fluorescent protein

BSA:

Bovine Serum Albumin

MTT:

3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide

DMSO:

Dimethyl sulfoxide

PI:

Propidium iodide

UFMS:

Federal university of mato grosso do sul

References

  1. Dai X, Xiang L, Li T, Bai Z. Cancer hallmarks, biomarkers and breast cancer molecular subtypes. J Cancer. 2016;7:1281–94.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. El Hachem G, Gombos A, Awada A. Recent advances in understanding breast cancer and emerging therapies with a focus on luminal and triple-negative breast cancer. F1000Research. 2019;8.

  3. Patten DK, Sharifi LK, Fazel M. New Approaches in the Management of Male Breast Cancer. Clin Breast Cancer. 2013;13:309–14.

    Article  PubMed  Google Scholar 

  4. Takahashi K, Yamanaka S. A decade of transcription factor-mediated reprogramming to pluripotency. Nat Rev Mol Cell Biol. 2016;17:183–93.

    Article  PubMed  CAS  Google Scholar 

  5. Gertz J, Reddy TE, Varley KE, Garabedian MJ, Myers RM. Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012;22:2153–62.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Sarkar A, Hochedlinger K. The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cell. 2013;12:15–30.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Mehta GA, Khanna P, Gatza ML. Emerging role of SOX proteins in breast cancer development and maintenance. J Mammary Gland Biol Neoplasia. 2019;24:213–30.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Li K, Wang R-W, Jiang Y-G, Zou Y-B, Guo W. Overexpression of Sox3 is associated with diminished prognosis in esophageal squamous cell carcinoma. Ann Surg Oncol. 2013;20:459–66.

    Article  CAS  Google Scholar 

  9. Yan Q, Wang F, Miao Y, Wu X. Sex-determining region Y-box3 (SOX3) functions as an oncogene in promoting epithelial ovarian cancer by targeting Src kinase. Tumor Biol. 2016;37:12263–71.

    Article  CAS  Google Scholar 

  10. Guo Y, Yin J, Tang M, Yu X. Downregulation of SOX3 leads to the inhibition of the proliferation, migration and invasion of osteosarcoma cells. Int J Oncol. 2018;52:1277–84.

    PubMed  Google Scholar 

  11. Cai QY, Liang GY, Zheng YF, Tan QY, Wang RW, Li K. Sox3 silencing inhibits metastasis and growth of esophageal squamous cell carcinoma cell via down-regulating GSK-3β. Int J Clin Exp Pathol. 2016;9:2939–49.

    CAS  Google Scholar 

  12. Acloque H, Ocaña OH, Matheu A, Rizzoti K, Wise C, Lovell-Badge R, et al. Reciprocal repression between Sox3 and Snail transcription factors defines embryonic territories at gastrulation. Dev Cell. 2011;21:546–58.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Comşa Ş, Cîmpean AM, Raica M. The story of MCF-7 breast cancer cell line: 40 years of experience in research. Anticancer Res. 2015;35:3147–54.

    PubMed  Google Scholar 

  14. Holliday DL, Speirs V. Choosing the right cell line for breast cancer research. Breast Cancer Res. 2011;13:215.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Feng Y, Xiao F, Yang N, Zhu N, Fu Y, Zhang H, et al. Overexpression of Sox3 is associated with promoted tumor progression and poor prognosis in hepatocellular carcinoma. Int J Exp Pathol. 2017;10:7873–81.

    Google Scholar 

  16. Vicentic JM, Drakulic D, Garcia I, Vukovic V, Aldaz P. SOX3 can promote the malignant behavior of glioblastoma cells. Cell Oncol Cellular Oncol. 2018;42:41–54.

    Article  Google Scholar 

  17. Song L, Liu D, He J, Wang X, Dai Z, Zhao Y, et al. SOX1 inhibits breast cancer cell growth and invasion through suppressing the Wnt/β-catenin signaling pathway. APMIS. 2016;124:547–55.

    Article  PubMed  CAS  Google Scholar 

  18. Das T, Nair RR, Green R, Padhee S, Howell M, Banerjee J, et al. Actinomycin D down-regulates SOX2 expression and induces death in breast cancer stem cells. Anticancer Res. 2017;37:1655–63.

    Article  PubMed  CAS  Google Scholar 

  19. Liang S, Furuhashi M, Nakane R, Nakazawa S, Goudarzi H, Ichi HJ, et al. Isolation and characterization of human breast cancer cells with SOX2 promoter activity. Biochem Biophys Res Commun. 2013;437:205–11.

    Article  PubMed  CAS  Google Scholar 

  20. Mehta GA, Parker JS, Silva GO, Hoadley KA, Perou CM, Gatza ML. Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer. Breast Cancer Res Treat. 2017;162:439–50.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  21. Zhang J, Liang Q, Lei Y, Yao M, Li L, Gao X, et al. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression. Cancer Res. 2012;72:4597–608.

    Article  PubMed  CAS  Google Scholar 

  22. Oliemuller E, Kogata N, Bland P, Kriplani D, Daley F, Haider S, et al. SOX11 promotes invasive growth and ductal carcinoma in situ progression. J Pathol. 2017;243:193–207.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Oliemuller E, Newman R, Tsang SM, Foo S, Muirhead G, Noor F, et al. Sox11 promotes epithelial/mesenchymal hybrid state and alters tropism of invasive breast cancer cells. Elife. 2020;9:1–29.

    Article  Google Scholar 

  24. Coutinho LM, Vieira EL, Dela Cruz C, Casalechi M, Teixeira AL, Del Puerto HL, et al. Apoptosis modulation by activin A and follistatin in human endometrial stromal cells. Gynecol Endocrinol. 2016;32:161–5.

    Article  PubMed  CAS  Google Scholar 

  25. Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader JA, Van Schie RCAA, LaFace DM, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of BCL-2 and Abl. J Exp Med. 1995;182:1545–56.

    Article  PubMed  CAS  Google Scholar 

  26. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2ΔΔCT method. Methods. 2001;25:402–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We thank the patients and volunteers who contributed to this research. We thank Doctor Amy Milsted very much for reviewing the manuscript.

Funding

Research supported by Federal University of Minas Gerais (Edital PRPq05/20160); This study was part of a PhD thesis by F.H.H.S. at the Pathology Post-Graduation Program at Universidade Federal de Minas Gerais, PhD scholarship funded by CAPES.

Author information

Authors and Affiliations

Authors

Contributions

FHSS: data curation, formal analysis, investigation, writing—original draft. AU: resources, supervision, writing—review and editing. CPA: data curation, formal analysis, investigation, writing—review and editing. TSR: data curation, investigation, writing—review and editing. EMSF: resources, investigation. ASM: resources, investigation. ME: methodology. SG: methodology, resources. LOA: data curation, resources, methodology. LR: data curation, methodology. HWG: data curation, methodology. CAO: resources, methodology. RCR: patient’s recruitment and sample curation. ITB: data curation, investigation, writing—review and editing. GDC: resources, investigation. EF: data curation, formal analysis, resources, supervision. HLDP: Conceptualization, formal analysis, funding acquisition, methodology, project administration, resources, supervision, writing -review and editing.

Corresponding author

Correspondence to Helen Lima Del Puerto.

Ethics declarations

Conflict of interest

The authors disclose no potential conflicts of interest.

Ethical approval and consent to participate

Informed consent was obtained from all the subjects before inclusion in the study, which was approved by the local Human Investigation Committee (CAAE 20636419.2.0000.0021).

Consent for publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary data (PDF 186 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Silva, F.H.d., Underwood, A., Almeida, C.P. et al. Transcription factor SOX3 upregulated pro-apoptotic genes expression in human breast cancer. Med Oncol 39, 212 (2022). https://doi.org/10.1007/s12032-022-01758-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-022-01758-0

Keywords

Navigation